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Glycosylphosphatidylinositol (GPI)-anchored molecules such as cell surface Gal/GalNAc lectin and proteo-
phosphoglycans of the protozoan parasite Entamoeba histolytica are thought to be involved in pathogenesis.
Here, we report the identification of genes that may be involved in the GPI biosynthetic pathway of E. histolytica
by use of bioinformatic tools applied to the recently published genome sequence. Of the genes identified, one
of the early genes, GlcNAc-phosphatidylinositol deacetylase (PIG-L), was partially characterized. Cell lines
deficient in E. histolytica PIG-L (EhPL-AS) or overproducing it (EhPL-S) were generated by expressing the gene
in the antisense or sense orientation, respectively, in a tetracycline-inducible system. The overexpressing cells
showed higher EhPIG-L activity and increased production of GlcN-PI. Conversely, cells expressing the anti-
sense RNA displayed reduced GlcN-PI production. The total number of GPI-containing molecules was also
reduced in these cells, as demonstrated by Alexa 488 fluorescently labeled proaerolysin labeling. The distri-
bution of GPI-linked PPG and Gal/GalNAc lectin was altered in the tetracycline-induced EhPL-AS cell lines.
Further, the antisense-blocked cells showed 36% suppression of cell growth, 50 to 60% inhibition of fluid phase
endocytosis, and about 50% inhibition of adhesion to target cells. Therefore, our data suggest the importance
of GPI anchors in regulating some of the events in amoebic pathogenesis. They also demonstrated the use of
antisense RNA-mediated inhibition of GPI biosynthetic enzymes as an approach to decrease the amount of GPI
conjugates in E. histolytica.
The intestinal protozoan parasite Entamoeba histolytica is
the causative agent of invasive amoebiasis, responsible for
about 40,000 deaths every year (22, 40). Glycoconjugates and
carbohydrate-binding proteins are involved in various disease
pathologies, including amoebiasis. Attachment of E. histolytica
trophozoites to target cells is required for cytolysis, and the
process is thought to be mediated by the cell surface Gal/
GalNAc lectin (44, 55). The glycocalyx layer on the surface of
pathogenic E. histolytica trophozoites is predominantly made
of proteophosphoglycan (PPG) (26, 41). No significant glyco-
calyx layer has been found on the surface of the nonpathogenic
Entamoeba dispar (34). This correlates with the absence of
PPG in E. dispar and suggests that PPG may have a role in
pathogenesis (2, 3). Both Gal/GalNAc lectin and PPG are
anchored to the plasma membrane by glycosylphosphatidyli-
nositol (GPI) anchors and have been suggested to be good
vaccine targets (19, 26). A number of reports emphasize the
role of glycoconjugates in pathogenesis of other protozoan
parasites (23, 36). For example, lipophosphoglycan (LPG) is
the predominant molecule on the surface of Leishmania pro-
mastigotes and is known to be involved in pathogenesis (17,
32). Promastigotes deficient in GPI-anchored gp63 and LPG
molecules displayed reduced virulence in terms of macrophage
infectivity (24, 28, 51, 52). LPG facilitated promastigote attach-
ment to the sandfly insect vector and provided resistance to
complement-mediated lysis of metacyclic forms and may be
essential for viability, replication, and/or virulence (24, 28, 33).
GPI-deficient Trypanosoma cruzi amastigotes differentiated
poorly to promastigotes and were inhibited in cellular growth
(1). Malarial GPI molecules were found to be potent toxins
closely associated with clinically severe malaria and capable of
inducing cytokine and adhesin expression in macrophages and
vascular endothelium (48). The glycan chain in the GPI was
suggested to be a good vaccine candidate (47).
The Gal/GalNAc lectin of E. histolytica consists of two sub-
units (heavy and light), of which the light subunit is GPI an-
chored (29). There is also an intermediate form (IGL) of the
lectin that colocalizes with the heavy and light subunits (10).
The IGL is also anchored to the membrane through a GPI
linkage. Cells expressing a dominant-negative form of the light
subunit of Gal/GalNAc lectin (LGL) showed reduced cytolysis
(21). Moreover, expression of truncated LGL molecules lack-
ing the capability to have GPI anchors in E. histolytica cells also
led to a reduction in virulence (30), suggesting that GPI an-
chors are important for lectin function and that the enzymes
involved in GPI biosynthesis may be potential drug targets.
GPIs share a common core structure (28). Typically phos-
phatidylinositol (PI) is glycosidically linked to the reducing end
of a nonacetylated glucosamine moiety, followed by three man-
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nose residues which, in turn, are attached to ethanolamine
linking the anchor to the protein destined to be GPI anchored
(28). However, the GPI anchors in E. histolytica have a unique
glycan backbone, that is, Gal-Man-Man-GlcN-myoinositol,
with the terminal mannose being replaced by -Gal, which is
not found in any other eukaryotic GPI core structures reported
so far (35). The biosynthesis of GPI anchors occurs in the
endoplasmic reticulum and involves the stepwise assembly of
the anchor on PI in the endoplasmic reticulum membrane (28).
Though there are a few species-specific modifications in terms
of the sequence of events, transfer of GlcNAc and deacetyla-
tion to form GlcN-PI appear to be the first two universal steps
in the GPI biosynthesis (12, 18). The GPI-GlcNAc-transferase
(GPI-Gnt) complex catalyzes the first step of the pathway, that
is, transfer of GlcNAc from UDP-N-acetylglucosamine to PI.
There are at least six subunits that make up the complex (58,
59, 61). On the other hand, a single polypeptide, PIG-L or
GPI12 (Saccharomyces cerevisiae), carries out the deacetyla-
tion reaction (37, 55).
The enzymes of GPI anchor biosynthesis are thought to be
excellent targets for chemotherapy in many parasite infections,
and GPI anchors have also been targets of immunoprophylaxis
(6, 26, 34, 47). Nothing is known about the GPI anchor bio-
synthetic pathway of E. histolytica and the enzymes that are
involved. In this report, we have identified the various compo-
nents of the pathway from sequence analysis of the E. histo-
lytica genome database. Further, we have characterized GlcNAc-
PI-deacetylase, the enzyme catalyzing the second step of GPI
biosynthetic pathway, and generated cell lines that are partially
blocked in this enzyme. These cells had an overall reduction of
total GPI-containing molecules and were altered in many bi-
ological parameters, such as growth, adhesion, and endocyto-
sis.
MATERIALS AND METHODS
Antibodies, strains and cell growth. Monoclonal antibody 2D7.10 was raised
against the PPG of E. histolytica strain HM-1:IMSS (5). Monoclonal anti-Gal/
GalNAc lectin 1D4 antibody (anti-LGL) was a kind gift of W. A. Petri (31).
All experiments were carried out with E. histolytica strain HM-1:IMSS clone 6,
which was obtained from William A. Petri (University of Virginia). The cells
were maintained and grown in TYI-33 medium supplemented with 15% adult
bovine serum, 2% Diamond’s vitamin mix, and antibiotic (0.3 units/ml penicillin
and 0.25 mg/ml streptomycin). Hygromycin (Sigma) was added at 10 g/ml for
maintaining the transformed cell lines. Cell viability was determined by micros-
copy using a trypan blue dye exclusion test. Experiments were conducted with
cells that showed 90% viability.
Sequence analysis. Amino acid sequences of genes involved in GPI anchor
biosynthesis from various organisms were retrieved from the “PIGs Main” server
(http://mendel.imp.univie.ac.at/sequences/gpi-biosynthesis/). Sequences that
were not available at “PIGs Main” were identified using the NCBI database
(http://www.ncbi.nlm.nih.gov). These were then used for BLAST analysis for a
search of the E. histolytica genome database (12.5 coverage, that is, the final
assembled genome sequence) at The Institute of Genome Research (http://www
.tigr.org/tdb/e2k1/eha1), the Wellcome Trust’s Sanger Institute (http://www
.sanger.ac.uk/Projects/E_histolytica), and NCBI. The identified genes from the
E. histolytica database were then further analyzed and confirmed by a number of
search tools using a variety of databases such as reverse BLAST, PSI-BLAST,
CD-search (http://www.ncbi.nlm.nih.gov/BLAST), Pfam (http://pfam.wustl.edu
/hmmsearch.shtml), MPSrch (http://www.ebi.ac.uk/MPsrch), and ProDom (http:
//www.sanger.ac.uk/software/Pfam). The transmembrane prediction of the pro-
tein was made using various programs available at Bioinformatics.Net (http:
//www.bioinformatics.vg/biolinks/bioinformatics/transmembrane%2520domains
.shtml). Determination of amino acid composition, translation of a given DNA
sequence, and multiple alignments (CLUSTALW) were performed using the
BioEdit sequence alignment editor (Tom Hall, version 7.0).
Metabolic labeling of cells. Mid-log-phase cells (2.5  105 cells/ml) were
incubated with radiolabeled precursor N-acetyl-D-[1-3H]glucosamine (Amer-
sham Biosciences) (100 Ci/ml) in TYI-S-33 medium for indicated time periods.
After incubation, the cells were harvested and washed twice with phosphate-
buffered saline (PBS).
Preparation of amoebic crude membranes and total cell lysate. Membranes
were prepared from E. histolytica as described previously by Carver and Turco
(9). Briefly, 4  107 cells were resuspended in 10 ml of HEPES buffer (100 mM
HEPES [pH 7.5], 50 mM KCl, 10 mM MnCl2, 10 mM MgCl2, 2 mM PMSF
[phenylmethylsulfonyl fluoride], 5 to 10 g/ml leupeptin) containing 10% glyc-
erol and lysed by glass Dounce tissue homogenizer at 4°C. The debris and
unbroken cells were removed by centrifugation at 250  g for 5 min. The
membrane fraction was collected by ultracentrifugation at 100,000  g for 1 h at
4°C. The membrane pellet was washed once with reaction buffer (50 mM HEPES
[pH 7.5], 5 mM EDTA, 1 g/ml leupeptin, 2 mM PMSF) without glycerol and
finally resuspended in the same buffer.
Total cell lysate was prepared as described previously (4). Briefly, the cells
were harvested and washed thrice with PBS. The cells were then lysed by hypo-
tonic shock (10 mM Tris-Cl [pH 7.5], 2 mM PMSF, 1 mM PHMB [p-hydroxymer-
curibenzoate], 4 g/ml leupeptin) for 10 min. After three cycles of freezing and
thawing at 70°C and 37°C, respectively, DNA was sheared by sonicating thrice
for 15 s. The lysate was stored as aliquots at 70°C.
In vitro synthesis of GPI pathway intermediates. Radiolabeled GPI interme-
diates were synthesized in vitro by incubating E. histolytica crude membrane
preparation (typically 1 mg protein) with UDP-[14C]GIcNAc (0.05 Ci) (Am-
ersham Biosciences) in reaction buffer in a total volume of 200 l. After incu-
bation at 37°C for 2 h, the reaction was stopped by incubating on ice. The labeled
products were extracted first by shaking with 600 l water and 3 ml ice-cold
chloroform-methanol (1:2 [vol/vol]) followed by addition of 1 ml each of chlo-
roform and water. The mixture was centrifuged at 1,000  g for 10 min at 4°C in
order to separate the phases. The lipid containing the chloroform-rich lower
phase was washed twice with 0.5 ml mock upper phase to remove any contam-
inating UDP-[14C]GlcNAc or breakdown products. Then, 10% of the lipid-
containing phase was taken for liquid scintillation counting. The remainder of
the sample was dried, dissolved in 20 l water-saturated butanol (w-butanol),
and analyzed by high-performance thin-layer chromatography (HPTLC).
HPTLC plates (Merck) were developed using chloroform–methanol–1 M am-
monium hydroxide (10:10:2 [vol/vol/vol]) as the solvent system. The plates were
air dried to remove any traces of ammonia followed by spraying with
EN3HANCE (NEN Life Science) for fluorography.
Characterization of GPI pathway intermediates. (i) Phenyl Sepharose chro-
matography. The extracted glycolipids were loaded on a 1 ml phenyl Sepharose
column equilibrated with 100 mM ammonium acetate–5% 1-propanol in water
(solvent A). A gradient was set up with various concentrations of solvent A and
solvent B (60% 1-propanol in water) at a flow rate of 4 ml/h. Then, 1-ml fractions
were collected and the amount of radioactive material in each fraction was
determined by liquid scintillation counting.
(ii) Enzymatic cleavage of glycolipids by PI-PLC treatment. Purified phos-
phatidylinositol-specific phospholipase C (PI-PLC) was obtained from Martin
Low (Columbia University College of Physicians and Surgeons, New York,
N.Y.). Radiolabeled products were treated with 0.1 U/ml of PI-PLC at 37°C for
indicated time periods, and the lipids were extracted as described above and
analyzed by HPTLC followed by fluorography.
(iii) Acetylation. The dried sample ([14C]-labeled glycolipids) was resuspended
in 50 l of saturated sodium bicarbonate, and 2 l of acetic anhydride was then
added. After 30 min of incubation on ice another 3 l of acetic anhydride was
added. The reaction mixture was further incubated at 20°C for 30 min. Acetyl-
ated glycolipids were extracted using w-butanol. The reaction mixture was again
washed with butanol, and the butanol phases were pooled and dried. The dried
acetylated product was resuspended in w-butanol and analyzed by HPTLC as
mentioned above.
(iv) Nitrous acid deamination. A total of 250 l of freshly prepared 0.4 M
NaNO2 (pH 5.5) was added to the dried [14C]-labeled glycolipids. The pH of the
reaction was adjusted to 3.5 to 4.0 using acetic acid, and then the reaction
mixture was incubated for 4 h. Further, 50 l of freshly prepared 1 M NaNO2 was
added and incubation was continued for another 8 h at room temperature. The
reaction was terminated by adding 250 l of w-butanol, and the reaction mixture
was mixed and then centrifuged for phase separation. The upper butanol phase
was removed, and the lower phase was reextracted with w-butanol. All the
butanol phases were pooled and dried using vacuum and then resuspended in 20
l of the same solvent. Deaminated glycolipids were subjected to HPTLC anal-
ysis.
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Northern hybridization. Total RNA was purified using TriPure reagent
(Roche Applied Science) according to the manufacturer’s instructions. RNA
samples (30 g) were denatured and size fractionated in a 1.2% formaldehyde
gel in 1 formaldehyde gel running buffer. The gel was processed using standard
molecular biology protocols and blotted onto a GeneScreen Plus nylon mem-
brane (NEN). It was hybridized with denatured radiolabeled probe in salmon
sperm DNA (100 g/ml) according to the manufacturer’s instructions. Radiola-
beled probes were prepared by using either random primers (for labeling double-
stranded probe) or strand-specific primers (for single-stranded probe) for a DNA
probe complementary to E. histolytica PIG-L (EhPIG-L) antisense RNA. The
double-stranded probe used was a 0.734-kb fragment containing the complete
coding region of EhPIG-L (double stranded); for identifying PIG-L antisense
RNA, the strand-specific primer 5-GGG GGA TCC CAT ATG GCT GAA
GCA CT-3 (PLAS-F) was used (single stranded).
PCR. Primers to amplify the EhPIG-L open reading frame were designed
based on sequences in the Entamoeba GSS sequence database. Appropriate
restriction enzyme sites were incorporated in the primers used for PCR ampli-
fication of the coding region of the EhPIG-L gene. The antisense forward and
reverse primers used were 5-GCG GGA TCC TCA CGA ATG TCT AGT ACA
ACA AT-3 (PLAS-F) and 5-GCG GGT ACC GTA ATA TTC AAC TAA
TTG ATT TAA-3 (PLAS-R). The sense forward and reverse primers were
5-GCG GGT ACC TCA CGA ATG TCT AGT ACA ACA AT-3 (PLS-F) and
5-GCG GGA TCC GTA ATA TTC AAC TAA TTG ATT TAA-3 (PLS-R).
Total genomic DNA was purified from late-log-phase-grown cells as described
earlier, and 200 ng of this DNA was used for PCR (7). The PCR conditions were
92°C for 7 min; 37°C for 1 min; 70°C for 1 min; 92°C for 30 s (5 cycles); 42°C for
1 min; 70°C for 1 min; 92°C for 30 s (25 cycles); 42°C for 1 min; and 70°C for 1
min (1 cycle). The PCR products were cloned in pGEMT-easy vector (Promega)
and subsequently in pEhHYG-tetR-O-CAT (15). The chloramphenicol acetyl-
transferase (CAT) gene was excised using KpnI and BamHI restriction endo-
nucleases, and the PIG-L gene was inserted in either the sense or the antisense
orientation. Plasmids containing PIG-L gene in sense and antisense orientations
were constructed and named pEhPL-S and pEhPL-AS, respectively. The cell
lines generated with parental vector (pEhHYG-tetR-O-CAT), pEhPL-S, and
pEhPL-AS constructs are referred to as vector, EhPL-S, and EhPL-AS, respectively.
PLS-F and PLS-R primers were used to amplify reverse-transcribed products
obtained from total HM1:IMSS RNA (5 g) under similar conditions, using
standard molecular biology protocols (46).
Transfection of E. histolytica trophozoites by electroporation. Transfection was
performed by electroporation as described previously (15, 60). Two consecutive
pulses were applied instead of one pulse, each with an exponential discharge of
3,000 V/cm at a capacitance of 25 F (Gene Pulser II; Bio-Rad). For each
transfection 1  107 trophozoites and 300 g DNA were used. Drug selection
with 10 g/ml hygromycin (Sigma) was started 48 h after transfection.
Immunostaining. E. histolytica cells (2  105) resuspended in incomplete
TYI-33 medium at 36°C were transferred onto coverslips placed in a petri dish
and allowed to adhere for 10 min at 36°C, and cells were fixed with 3.7%
prewarmed paraformaldehyde for 30 min at 36°C. After fixation, the cells were
permeabilized with 0.1% Triton X-100–PBS for 1 min and then quenched with 50
mM NH4Cl–PBS for 30 min. The coverslips were blocked with 1% bovine serum
albumin (BSA)–PBS for 30 min, followed by incubation with monoclonal anti-
body for 1 h at 36°C. These were first washed with PBS and then with 1%
BSA–PBS before incubation with secondary antibodies at a 1:200 dilution for 30
min at 36°C. The combinations of antibodies used were monoclonal antibody
2D7.10 (anti-PPG) at 1:100 along with cy3-labeled anti-mouse immunoglobulin
G (IgG) and monoclonal anti-Gal/GalNAc lectin antibody 1D4 (anti-LGL) at
1:30 in combination with Alexa-488-labeled anti-mouse IgG at 1:200 dilution.
The preparations were further washed with PBS and mounted on a glass slide
using DABCO [1,4-diazbicyclo(2,2,2)octane] (Sigma) (10 mg/ml) in 80% glycerol
and sealed. Cy3-labeled and Alexa-488-labeled cells were visualized using a laser
scanning confocal microscope (FV300 Olympus) after excitation at 543 nm and
488 nm, respectively.
TABLE 1. Putative GPI biosynthetic pathway enzymes of E. histolytica, yeast, and humans
Enzyme Humangene
S. cerevisiae
gene
E. histolytica
gene
Accession no./genomic locus
of E. histolytica genes
GPI-GlcNAc-transferase complex (GPI-GnT complex) PIG-A GPI3 EhPIG-A EAL51260/AAFB01000048
PIG-C GPI2 EhPIG-C EAL48156/AAFB01000298
PIG-H GPI15 NDa
PIG-P PIG-P EhPIG-P EAL47301/AAFB01000388
EAL47099/AAFB01000406
EAL47075/AAFB01000408
EAL43001/AAFB01001119
PIG-Q GPI1 EhPIG-Q EAL49884/AAFB01000136
DPM2 ND ND
GPI-deacetylase PIG-L GPI-12 EhPIG-L EAL49111/AAFB01000209
MTI PIG-M GPI10 EhPIG-M EAL44694/AAFB01000708
EAL47045/AAFB01000410
MTII PIG-X Pbn1p EhPIG-X EAL43352/AAFB01001009
EAL49190/AAFB01000202
MTIII PIG-V GPI18 EhPIG-V EAL48755/AAFB01000238
PIG-B GPI14 ND
MTIV SMP3 SMP3 ND
Dol-P-man-synthase DPM1 DPM1 EhDPM1 EAL46013/AAFB0100
Phosphoethanolamine transferase complex PIG-N MCD4 ND
GPI7 GPI7 ND
PIG-O GPI13 EhPIG-O EAL47397/AAFB01000376
PIG-F GPI11 ND EAL50726/AAFB01000082
GPI-transamidase complex GPAA1 GAA1 ND
PIG-K GPI8 EhPIG-K EAL49152/AAFB01000205
PIG-S GPI17 EhPIG-S EAL47456/AAFB01000369
PIG-T GPI16 EhPIG-T EAL47777/AAFB01000333
PIG-U Cdc91p EhPIG-U EAL44658/AAFB01000711
EAL47069/AAFB01000408
GPI-deacylase PIG-W GWT1 EhPIG-W EAL48691/AAFB01000242
a ND, not detected.
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FLAER labeling to map GPI conjugate. Proaerolysin is a nontoxic precursor of
a 47-kDa channel-forming protein aerolysin and is generated by proteolytic
processing. The binding of proaerolysin to lipid bilayers was studied with Alexa
488-labeled proaerolysin (fluorescently labeled proaerolysin [FLAER]), and the
labeled cells were analyzed by confocal microscopy (8). Briefly, E. histolytica cells
(1 105) were harvested and resuspended in incomplete TYI-33 medium. These
were then incubated with 108 M FLAER (Protox Biotech) at 20°C for 1 h. The
cells were washed with PBS to remove unbound FLAER and fixed in 3.7%
paraformaldehyde for 30 min at 36°C. The labeled cells were visualized using a
laser scanning confocal microscope after excitation at 488 nm.
Cellular proliferation. E. histolytica cells transfected with pEhPL-AS and pa-
rental vector were grown in the presence of 10 g/ml hygromycin B, and the
growth was measured in the absence and the presence of 10 g/ml tet after 72 h.
The cells were counted with a hemocytometer. Cell viability was determined by
microscopy using a trypan blue dye exclusion test.
FITC-dextran uptake analysis. The endocytosis in E. histolytica was studied by
observing the uptake of fluorescein isothiocyanate (FITC)-dextran. The mid-log-
phase cells were harvested, washed, and resuspended in PBS. The cells were
incubated with FITC-dextran (FD-40; Sigma) (2 mg/ml) for 30 min at 36°C. The
slides were visualized under a fluorescent microscope (Axioscope plus; Zeiss).
The amount of FITC-dextran uptake was determined by first lysing the FITC-
dextran containing trophozoites in PBS containing 0.1% nonionic detergent
(Nonidet) NP-40 and then measuring fluorescence emission at 520 nm, using a
fluorescence spectrophotometer (Varion; Cary) with the excitation wavelength at
485 nm.
Target cell adherence assays. (i) Adherence to CHO cells. Rosette formation
was assayed as described previously (43). Briefly, E. histolytica (1  103) and
CHO (2  104) cells were mixed in 1 ml of TYI-S-33 medium and then centri-
fuged at 150  g for 5 min. The amoeba and CHO cell pellet was transferred to
24-well culture plates and further coincubated for 2 h with gentle shaking. E.
histolytica cells with at least three adhered CHO cells (referred to as an amoeba-
CHO cell rosette) were counted under an inverted light microscope (Nikon) at
40 magnification.
(ii) Adherence to HRBCs. Fresh human erythrocytes (HRBCs) were obtained
from healthy donors and were washed with PBS and centrifuged. The pellet was
resuspended in TYI-S-33 medium. Amoeba and HRBCs were coincubated to-
gether at a 1:20 ratio, and adherence was calculated as described earlier for CHO
cells.
Miscellaneous methods. The concentration of protein in a sample was esti-
mated using an bicinchoninic acid assay with BSA as a standard (50). The paired
t test was used to calculate the statistical significance of any differences between
the experimental groups. Statistical significance was set at P  0.05.
RESULTS
GPI anchor biosynthetic pathway genes in E. histolytica. The
biosynthesis of GPI anchors is a multistep process involving
many intermediates. A number of enzymes and enzyme com-
plexes participate in these steps leading to the synthesis of
GPI-anchored molecules. Data from other biological systems
suggest the presence of at least 10 reaction steps for the GPI
core biosynthesis, and more than 20 genes may be involved in
this pathway (13).
In an effort to understand and elucidate the GPI biosynthe-
sis pathway in E. histolytica we undertook a detailed computa-
tional analysis of the E. histolytica genome (12.5 coverage)
(25). Using the amino acid sequences of known genes of GPI
biosynthesis pathway from other organisms such as yeast and
humans and Leishmania and Trypanosoma spp. as queries, we
searched for their corresponding homologues in E. histolytica.
The hits were considered significant when the maximum e-
value obtained in the BLAST analysis was 0.00001. Some of
the hits were also confirmed by the presence of motifs or of
demonstrated similarity with protein families by use of “Pro-
site” and “Pfam.” Out of a total of 22 genes in yeast and 23 in
humans only 15 genes were identified in E. histolytica (Table
1). It is difficult to say at present whether homologs of proteins
present in other organisms and not found in E. histolytica are
missing or have diverged significantly so that these are not
detectable in spite of the use of sensitive search methods.
Interestingly, the proteins that were found to be absent in E.
histolytica by database search were not the catalytic subunits of
multienzyme complexes (Table 1). It appears from these data
that the GPI biosynthetic pathway of E. histolytica is likely to
be substantially different from that present in other organisms.
Since the deacetylase activity is carried out by a single subunit
FIG. 1. The EhPIG-L gene of E. histolytica. ClustalW alignment of EhPIG-L protein (Eh) with those of Leishmania (Lm), Trypanosoma (Tb),
and human (Hs) homologs, respectively. The boxed regions show a conserved Pfam domain (PF02585) common to all PIG-L proteins. Black- and
gray-shaded regions indicate identical and similar amino acids. Amino acid positions are indicated on the left.
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encoded by PIG-L, we subsequently focused our studies on this
gene.
Sequence analysis of EhPIG-L gene. The putative E. histo-
lytica EhPIG-L gene (EAL49111.1) showed 33% identity and
47.5% similarity with the human PIG-L gene. E. histolytica
PIG-L encodes a putative protein of 237 amino acids, with a
predicted size of about 27 kDa. ClustalW alignment with the
proteins from human and other protozoan parasites showed
significant regions of conservation dispersed over the length
of the protein (Fig. 1). A conserved Pfam domain (acces-
sion number PF02585) common to all PIG-L orthologs was
also found in EhPIG-L spanning amino acid positions 39 to
154.
GlcNAc-PI-deacetylase activity in E. histolytica membrane
vesicles. Data presented in the previous section showed the
presence of a putative GlcNAc-PI-deacetylase gene in the E.
histolytica genome. In order to show whether such an activity
exists in these cells, biochemical assays were performed for the
first two enzymes, namely, GPI-N-acetylglucosamine trans-
ferase (GPI-Gnt complex) and GlcNAc-PI-deacetylase (PIG-
L), in a cell-free system containing microsomal membranes (9).
The cell-free system was incubated with UDP-[14C]GlcNAc,
and the products were analyzed by HPTLC as described in
Materials and Methods. The products resolved into two major
radiolabeled products, X and Y, which migrated slower than PI
(Fig. 2A). The products (X and Y) migrated with Rf values of
0.76 and 0.72, respectively. The values were found to be similar
to those of GlcNAc-PI and GlcN-PI as reported for other
organisms, such as mammals, yeast, and Leishmania spp.
In order to show that the reaction products were indeed
GlcNAc-PI and GlcN-PI, further analysis was carried out. The
radiolabeled reaction products bound phenyl Sepharose and
were found to elute at 30% n-propanol, a property typical of
many GPI-anchored molecules (references 9 and 14 and data
not shown). The reaction products were susceptible to PI-PLC
hydrolysis (Fig. 2B). About 85% of the material was digested
within 1 h when incubated with 0.1 U/ml of PI-PLC (data not
shown). Since the bulk of the radioactivity released was in the
aqueous phase migrating near the origin (Fig. 2B, Lane 2), it
suggested that a glycan group may have been generated after
FIG. 2. Cell-free biosynthesis of GPI intermediates and their characterization. (A) HPTLC profile of in vitro reaction products. E. histolytica
crude membranes (2  107 cells) were incubated with UDP-[14C]GlcNAc (0.05 Ci) in reaction buffer and analyzed by HPTLC as described in
Materials and Methods. Two major radiolabeled products, X and Y, were identified by fluorography. The position of PI is indicated by an arrow.
(B) PI-PLC hydrolysis of products shown in panel A. Lane 1, untreated intermediates (Rf values: X 	 0.78; Y 	 0.72); lane 2, PI-PLC-hydrolyzed
products in aqueous phase (Rf value 	 0.3); lane 3, PI-PLC-hydrolyzed products in organic phase. (C) Nitrous acid deamination. Radiolabeled
glycolipid products of in vitro reactions were subjected to nitrous acid deamination followed by HPTLC analysis and fluorography. Lane 1,
untreated sample; lane 2, HNO2-treated sample. (D) Acetic anhydride acetylation. HPTLC profile of radiolabeled glycolipids after N acetylation
by acetic anhydride. Lane 1, untreated glycolipids; lane 2, acetic anhydride-treated glycolipids.
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the digestion. Both the products were susceptible to digestion
by the enzyme (Fig. 2B, lane 3).
The susceptibility to nitrous acid deamination is also a di-
agnostic feature of a GPI-anchored molecule. After nitrous
acid deamination, the glycolipids labeled in vitro were hydro-
lyzed, as revealed by loss of product Y only, unlike the results
seen with PI-PLC treatment (Fig. 2C). This showed that one of
the products (Y) contains a PI anchor with a free amine, which
may have been generated through a deacetylation reaction.
In order to conclusively show the identity of the deacetylated
intermediate, reaction products were subjected to N-acetyla-
tion by acetic anhydride. This would convert GlcN-PI to GlcNAc-
PI, which would be reflected in the shifting of the position in
HPTLC. Y was found to comigrate with X after acetylation,
indicating that X was the acetylated derivative of Y (Fig. 2D).
These observations confirmed that the products X and Y were
GlcNAc-PI and GlcN-PI, respectively.
Molecular characterization of EhPIG-L gene. The nucleo-
tide sequence of the predicted gene, EhPIG-L, was used to
design PCR primers PLS-F (forward) and PLS-R (reverse),
and the PCR amplicon was cloned and sequenced. The endog-
enous expression of the gene in E. histolytica was examined by
Northern blotting. A single transcript of about 0.9 kb was
observed in Northern blot analysis (Fig. 3A). The extra nucle-
otides in the transcript compared with the coding region may
be contributed by untranslated regions and a poly(A) tail.
Reverse transcription-PCR also showed the presence of a band
of expected size (data not shown). These results suggested that
the putative PIG-L of E. histolytica is expressed in trophozoites.
Inducible expression of PIG-L. A tetracycline-inducible
gene expression system for E. histolytica was reported previ-
ously (45). Molecular cloning of the PIG-L gene in pEh-HYG-
tetR-O-CAT vector has been described in Materials and Meth-
ods and is schematically shown in Fig. 3B.
FIG. 3. Expression of EhPIG-L in cultured and transformed E. histolytica cells. Total RNA was extracted from trophozoites of E. histolytica,
and 30 g was used for Northern analysis as described in Materials and Methods. (A) Endogenous expression of EhPIG-L in cultured E. histolytica
cells. The blot was hybridized with the full-length coding region of EhPIG-L. Molecular mass markers are in kilobase pairs. (B) Schematic
description of a plasmid pEhHYG-tetR-O-CAT. The CAT gene of the E. histolytica shuttle vector pEhHYG-tetR-O-CAT was excised using KpnI
and BamHI. The EhPIG-L gene was inserted in its place in either the sense (pEhPL-S) or the antisense (pEhPL-AS) orientation. Northern analysis
of RNA was performed using the cell lines transformed with pEhPL-AS (C) and pEhPL-S (D), and the blots were hybridized under stringent
conditions with single-stranded DNA probe complementary to EhPIG-L antisense-RNA (ss) and a double-stranded EhPIG-L probe (ds). For
probing antisense RNA, specific primer PLAS-F was used. E. histolytica rRNA gives two bands at 1.6 kb and 1.9 kb, respectively. K, KpnI, B,
BamHI; HYG, 1 kb, TetR, 0.61 kb, CAT, 0.65 kb, pBS, 3.19 kb.
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In order to determine expression levels of EhPIG-L in over-
expressing (EhPL-S) and antisense-blocked (EhPL-AS) cells,
Northern hybridization of EhPIG-L was carried out using the
entire EhPIG-L coding region in the presence and the absence
of tetracycline. In EhPL-AS cells a high level of expression of
antisense PIG-L was observed in the presence of tet (Fig. 3C;
ss). However, there was a twofold reduction in EhPIG-L tran-
scripts in EhPL-AS cells when the double-stranded gene was
used in Northern analysis (Fig. 3C; ds). There was a fivefold
increase in the expression of the PIG-L gene upon addition of
10 g/ml tet for 72 h in EhPL-S cells (Fig. 3D; ds). The results
demonstrated the usefulness of the tet-regulated system for
conditional expression of a gene in E. histolytica and showed
that EhPIG-L expression can be down regulated in EhPL-AS
cells upon addition of tet.
The transformed cell lines were further characterized bio-
chemically by use of the cell-free system described earlier (58)
to analyze the activities of GPI-Gnt complex and PIG-L. Equal
amounts of extracted radiolabeled glycolipids (20,000 to 30,000
for different experiments) were subjected to HPTLC analysis.
The ratio of the two products, namely, GlcNAc-PI and GlcN-
PI, is indicative of the amount of PIG-L present in the cells.
Extracts from EhPL-S cells grown in the presence of tet
showed an accumulation of radioactive GlcN-PI and a reduc-
tion in GlcNAc-PI levels (Fig. 4A). The ratio of GlcN-PI to
GlcNAc-PI was found to be 1.14 and 2.18 in the absence and
the presence of tet, respectively, in a typical experiment (Fig.
4B). These experiments were repeated a number of times (n 	
4); there was a statistically significant difference (P value 
0.05) in the ratio of GlcN-PI to GlcNAc-PI in the presence and
the absence of the inducer. This result is expected if the puta-
tive gene codes for PIG-L enzyme whose levels rise in cells in
the presence of tet. The converse is expected from EhPL-AS
cells, where tet induction would lead to production of antisense
RNA and thus inhibition of gene expression (Fig. 4C). In these
cells the ratios of GlcN-PI to GlcNAc-PI were found to be
0.882 and 0.445 before and after tet induction, respectively,
suggesting an increase in acetylated product (Fig. 4D).
The level of GPI-containing molecules. Aerolysin and
proaerolysin have been shown to bind with high affinity to
GPI-anchored molecules on the cell surface and therefore can
be used to map GPI anchors quantitatively (8). The binding of
proaerolysin to lipid bilayer was studied with FLAER, and the
labeled cells were analyzed by confocal microscopy as de-
scribed in Materials and Methods. This analysis indicated that
there was a reduction of 85 to 90% in the number of fluores-
cent foci upon tet induction of EhPL-AS cells (Fig. 5A). The
cells containing the parental vector showed no statistically
significant change in labeling in the presence of tet (Fig. 5B).
This indicated that the antisense RNA-mediated blocking of
EhPIG-L gene expression led to a reduction in the amount of
GPI-containing molecules on the amoebic cell surface.
FIG. 4. GlcN-PI and GlcNAc-PI synthesis in EhPIG-L antisense (EhPL-AS) and EhPIG-L sense (EhPL-S) cells. Crude membranes were
prepared from cells grown in the absence () and the presence () of tet. The cell-free assay was carried out as described earlier using 0.8 mg
of respective membrane preparation. Glycolipids were extracted, and equal amounts of radioactivity (20,000 to 30,000 cpm for the different
experiments) were used for HPTLC analysis followed by fluorography. The histogram represents the product-to-substrate ratio (GlcN-PI/GlcNAc-
PI), based on four separate experiments. (A) HPTLC profile of EhPL-S cells, in the absence () and the presence () of tet. (B) Densitometric
analysis of radiolabeled glycolipids extracted from EhPL-S cells for uninduced () and induced () states. (C) HPTLC profile of EhPL-AS cells,
in the absence () and the presence () of tet. (D) Densitometric analysis of glycolipids extracted from EhPL-AS cells for uninduced () and
induced () states.
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The expression of GPI-containing PPG and the small sub-
unit of Gal/GalNAc lectin were studied in EhPL-AS cells by
confocal fluorescence microscopy after immunostaining. The
images are shown in Fig. 6. PPG was found mainly on the cell
surface, and a uniform distribution was observed on EhPL-AS
cells in the absence of tet (Fig. 6A, PPG). However, after
induction most of the stained material was in the intracellular
vacuoles and not on the cell surface (Fig. 6B, PPG). The
specific staining of Gal/GalNAc lectin revealed a pattern of
granular distribution spread over the cell as observed previ-
ously for the lectin (21). After tet induction the level of staining
was also reduced significantly, but its distribution seemed to be
unaffected (Fig. 6C and 6D; LGL). It appears from these
results that there is a reduction in the number of GPI mole-
cules in EhPIG-L expression-blocked cells.
Functional characterization of transformed cells. Cell pro-
liferation is one of the key indicators of an altered cell physi-
ology. Cell proliferation was determined in relation to anti-
sense PIG-L expression. Cell number of EhPL-AS cells was
found to decrease by 31 to 36% (P value  0.01) in different
experiments in the presence of tet for 72 h (Fig. 7A). No
significant change was observed in cell proliferation when a
control cell line carrying the parental vector was used.
In order to investigate the role of GPI-anchors in cytoadhe-
sion, an assay involving binding of transformed E. histolytica
trophozoites to CHO and HRBCs was performed. There was a
40% reduction in adherence of both CHO cells and HRBCs to
EhPL-AS cells in the presence of tet compared to the results
seen with cells grown without tet or the cells carrying the
parental vector in the presence of the inducer (Fig. 7B). The
quantum of reduction differed from experiment to experiment,
ranging from 40 to 60%. This result suggests that GPI anchors
are important for amoebic adhesion, as already known for one
of the GPI conjugates in E. histolytica (Gal/GalNAc lectin).
The level of endocytosis was measured by determining the
uptake of FITC-dextran. The level of FITC-dextran uptake in
tet-induced EhPL-AS cells was found to be reduced by 50 to
60% compared to uninduced cell results. The cells containing
vector alone did not show any significant change in uptake in
the presence or the absence of the inducer (Fig. 7C). Fluores-
cent microscopic analysis of the cells showed similar results.
The number of fluorescent pinocytic vesicles was reduced in
EhPL-AS cells in the presence of tet (Fig. 7C). The results
suggested that the level of endocytosis is reduced by antisense
inhibition of PIG-L gene expression.
DISCUSSION
GPI-anchored molecules are involved in important pro-
cesses in a variety of cell types and organisms. The amount and
type of such molecules differ in different organisms, being less
abundant in mammalian cells than in yeast and protozoa. In-
terestingly, GPI-anchored molecules in some of these organ-
isms are thought to be involved in parasitism and pathogenesis
(23, 36). The two major GPI-anchored cell surface molecules
of E. histolytica, PPG and Gal/GalNAc lectin, are thought to be
FIG. 5. Labeling of cell surface GPI-linked molecules by FLAER. EhPL-AS cells (2 105) were incubated with 108 M FLAER for 1 h at 20°C.
The cells were then centrifuged and washed with PBS to remove unbound FLAER and subsequently fixed in 3.7% paraformaldehyde for 30 min
at 37°C. The washed cells were resuspended in PBS and mounted on slides using 10 mg/ml DABCO in 80% glycerol. The fluorescent samples were
examined on a laser-scanning confocal microscope (FV300 Olympus, Japan) equipped with a 60 objective. FLAER-labeled samples were
visualized after excitation at 488 nm. (A) EhPL-AS cells, in the absence () and the presence () of tet. (B) Vector cells, in the absence () and
the presence () of tet. DIC, differential interference contrast.
FIG. 6. Immunostaining of PPG and Gal/GalNAc lectin in EhPL-AS cells. Trophozoites grown for 72 h were transferred to prewarmed,
acetone-washed coverslips for 10 min at 36°C. The cells were then fixed with paraformaldehyde-PBS and permeabilized with 0.1% Triton–PBS
followed by immunostaining with indicated antibodies. The stained cells were then visualized after excitation at 543 nm (for Cy3) and 488 nm (for
Alexa-488) on a confocal laser scanning microscope (FV300 Olympus, Japan) equipped with a 60 objective. Panels A and B were stained with
monoclonal anti-PPG antibody 2D7.10 followed by cy3-labeled anti-mouse IgGs, whereas panels C and D were stained with monoclonal
anti-Gal/GalNAc lectin antibody 1D4 followed by Alexa488-labeled anti-mouse IgGs. Panels A and C show uninduced cells; panels B and D show
tet-induced cells. DIC, differential interference contrast.
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FIG. 7. Functional characterization of pEhPL-AS-transformed cells. (A) Growth of cell lines transfected with pEhPL-AS and vector constructs.
All cells were grown in the presence of 10 g/ml hygromycin B, and growth was measured in the absence and the presence of tet for 72 h. (B) Target
cell adherence. An adherence assay was performed as described in Materials and Methods. E. histolytica cells were incubated with target cells, and
the numbers of amoebae with three or more adherent target cells (CHO cells and HRBCs) were estimated. (C) Fluid-phase endocytosis. EhPL-AS-
and vector-transformed cells were incubated with 2 mg/ml FITC-dextran in PBS for 30 min and subjected to quantitative estimation by
spectrofluorimeter as described in Materials and Methods. The cells (right panels) were also mounted on glass slides for viewing under a
fluorescent microscope (Axioscope plus; Zeiss) at 40 magnification. Some of the error bars are not visible due to small values. (*, P value  0.05;
**, P value  0.01; ***, P value  0.001).
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key molecules involved in amoebic pathogenesis (3, 26, 34, 41,
53, 54). In this study an attempt was made to generate cell lines
that have reduced levels of overall GPI-containing molecules
and to correlate this reduction with functional characteristics.
The approach used was to block expression of one of the early
enzymes in the pathway.
At the outset the presence of GPI-Gnt complex and PIG-L
activities in E. histolytica was demonstrated using a cell-free
system. The products of these enzyme activities were suscep-
tible to PI-PLC hydrolysis. Nitrous acid deamination revealed
that one of the products (Y) contains a PI anchor with a free
amine, which may have been generated through a deacetyla-
tion reaction. These products were interconvertible by acety-
lation and deacetylation. Thus, the data put together con-
firmed that products X and Y were GlcNAc-PI and GlcN-PI,
respectively.
One of the ways to decipher the function of a molecule is to
generate a knockout cell line or block expression of specific
genes. Generating gene knockouts in E. histolyitca has not been
possible because of the high ploidy of this organism (57).
Therefore, expression blocking appears to be a better option
for functional studies. Since some of the genes may be essential
for proliferation, an inducible antisense approach was adopted.
Such an approach utilizing the inducible tet repressor-operator
system was previously shown to be useful in generating condi-
tional expression blocking of a calcium binding protein gene of
E. histolytica (45). In this study, in silico approaches were used
to identify genes encoding the enzymes involved in the biosyn-
thetic pathway of GPI. Since some of these genes were con-
served, it was possible to find these enzymes, and one of the
first enzymes, PIG-L, was used for expression blocking of the
pathway by the antisense approach. The rationale for targeting
one of the first enzymes is to block all types of GPI anchors and
not necessarily some specific class of GPI-containing molecules.
The data presented here show that the putative PIG-L of
E. histolytica is indeed a GlcNAc-PI-deacetylase by the follow-
ing criteria. (i) EhPIG-L has 33% overall sequence identity
with human PIG-L. A conserved domain is also present in
EhPIG-L. (ii) E. histolytica cells partially blocked for PIG-L
expression, when subjected to conditional tet induction,
showed lower levels of deacetylase activity. Conversely, when
EhPIG-L was overexpressed, the deacetylase activity was
found to increase. These results demonstrated the usefulness
of a system regulated by tet for conditional expression of the
PIG-L gene in E. histolytica. (iii) The total repertoire of GPI-
anchored molecules in the PIG-L-blocked cells was reduced by
85 to 90% as visualized by FLAER labeling. This was also
confirmed by measuring the amount of PPG and Gal/GalNAc
lectin light subunit in these cells. The antisense-inhibited cells
showed a reduction in the levels of both molecules. Expression
blocking of EhPIG-L resulted in partial inhibition of E. histo-
lytica cell proliferation. This observation was similar to results
seen with yeast and trypanosomes, where genes known to be
involved in GPI anchor biosynthesis were essential for viability
(16, 36).
GPI-anchored molecules are thought to participate in endo-
cytosis (11, 27, 38, 49). Loss of endocytosis and an inhibition in
adherence would reduce the pathogenic potential of E. histo-
lytica. Here we showed that partial blocking of the EhPIG-L
gene leads to reduction in the amoebic cell surface adhesion to
target cells and a decrease in fluid phase pinocytosis. These
observations are consistent with the previous finding that over-
expression of a mutant form of the small subunit of Gal/
GalNAc lectin lacking the GPI anchor reduced the pathogenic
properties of the cells (42).
Blocking of a complete biosynthetic pathway by inhibiting a
key enzyme has been achieved in many organisms (20, 39, 56).
This is one of the first examples of such an approach in the
protozoan parasite E. histolytica. This is also the first report
describing some of the events in the biosynthesis of GPI an-
chors in E. histolytica.
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